Terms: = Breast cancer AND HNRNPA2B1, ENSG00000122566, SNRPB1, RNPA2, HNRPB1, HNRPA2, HNRNPB1, HNRNPA2, 3181 AND Treatment
13 results:
1. Cullin-associated and neddylation-dissociated 1 regulate reprogramming of lipid metabolism through SKP1-Cullin-1-F-box
Zhang H; Xia P; Yang Z; Liu J; Zhu Y; Huang Z; Zhang Z; Yuan Y
Clin Transl Med; 2023 Oct; 13(10):e1443. PubMed ID: 37837399
[TBL] [Abstract] [Full Text] [Related]
2. A2/B1 Promotes NRF2 mRNA Stability and Inhibits Ferroptosis and Cell Proliferation in breast cancer Cells.
Huang Y; Chen J; Pan J; Yang Y; Huang H; Lai H; Yang L; Ai H
Biomed Res Int; 2023; 2023():2620738. PubMed ID: 37090185
[TBL] [Abstract] [Full Text] [Related]
3. Conventional cardiac risk factors associated with trastuzumab-induced cardiotoxicity in breast cancer: Systematic review and meta-analysis.
Koulaouzidis G; Yung AE; Yung DE; Skonieczna-Żydecka K; Marlicz W; Koulaouzidis A; Charisopoulou D
Curr Probl Cancer; 2021 Oct; 45(5):100723. PubMed ID: 33726923
[TBL] [Abstract] [Full Text] [Related]
4. The effect of omission of adjuvant radiotherapy after neoadjuvant chemotherapy and breast conserving surgery with a pathologic complete response.
Mandish SF; Gaskins JT; Yusuf MB; Amer YM; Eldredge-Hindy H
Acta Oncol; 2020 Oct; 59(10):1210-1217. PubMed ID: 32716227
[TBL] [Abstract] [Full Text] [Related]
5. Chest wall resection and reconstruction for recurrent breast cancer - A multidisciplinary approach.
Menon A; Khalil H; Naidu B; Bishay E; Steyn R; Kalkat MS
Surgeon; 2020 Aug; 18(4):208-213. PubMed ID: 31917085
[TBL] [Abstract] [Full Text] [Related]
6. Increased Expression of Exosomal AGAP2-AS1 (AGAP2 Antisense RNA 1) In breast cancer Cells Inhibits Trastuzumab-Induced Cell Cytotoxicity.
Zheng Z; Chen M; Xing P; Yan X; Xie B
Med Sci Monit; 2019 Mar; 25():2211-2220. PubMed ID: 30910994
[TBL] [Abstract] [Full Text] [Related]
7. Epidemiological evaluation of the outcomes after video-assisted thoracoscopic talcage in neoplastic pleurisy.
Bosînceanu M; Sandu C; Roată CE; Ionescu LR; Miron L
Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):112-8. PubMed ID: 25970953
[TBL] [Abstract] [Full Text] [Related]
8. Clinical significance of the lymphoscintigraphy in the evaluation of non-axillary sentinel lymph node localization in breast cancer.
Gherghe M; Bordea C; Blidaru A
Chirurgia (Bucur); 2015; 110(1):26-32. PubMed ID: 25800312
[TBL] [Abstract] [Full Text] [Related]
9. Outcome of breast cancer screening: a Lebanese single institution experience.
Kourie HR; Daher A; Matar D; Antoun J; Salloum L; Kattan J
Asian Pac J Cancer Prev; 2014; 15(21):9471-3. PubMed ID: 25422257
[TBL] [Abstract] [Full Text] [Related]
10. Five-year local control in a phase II study of hypofractionated intensity modulated radiation therapy with an incorporated boost for early stage breast cancer.
Freedman GM; Anderson PR; Bleicher RJ; Litwin S; Li T; Swaby RF; Ma CM; Li J; Sigurdson ER; Watkins-Bruner D; Morrow M; Goldstein LJ
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):888-93. PubMed ID: 22580118
[TBL] [Abstract] [Full Text] [Related]
11. Safety and activity of trastuzumab-containing therapies for the treatment of metastatic breast cancer: our long-term clinical experience (GOIM study).
Adamo V; Franchina T; Adamo B; Ferraro G; Rossello R; Maugeri Saccà M; Scibilia C; Valerio MR; Russo A
Ann Oncol; 2007 Jun; 18 Suppl 6():vi11-5. PubMed ID: 17591801
[TBL] [Abstract] [Full Text] [Related]
12. Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost.
Freedman GM; Anderson PR; Goldstein LJ; Ma CM; Li J; Swaby RF; Litwin S; Watkins-Bruner D; Sigurdson ER; Morrow M
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):347-53. PubMed ID: 17379430
[TBL] [Abstract] [Full Text] [Related]
13. Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial.
De Maio E; Pacilio C; Gravina A; Morabito A; Di Rella F; Labonia V; Landi G; Nuzzo F; Rossi E; Silvestro P; Botti G; Di Bonito M; Curcio MP; Formichelli F; La Vecchia F; Staiano M; Maurea N; D'Aiuto G; D'Aiuto M; Thomas R; Signoriello G; Perrone F; de Matteis A
BMC Cancer; 2007 Mar; 7():50. PubMed ID: 17374151
[TBL] [Abstract] [Full Text] [Related]
